Evidence map›Paper›PMID 30510213›Full record

ArticleNature communications2018

MTCH2-mediated mitochondrial fusion drives exit from naïve pluripotency in embryonic stem cells.

Amir Bahat, Andres Goldman, Yehudit Zaltsman, Dilshad H Khan, Coral Halperin, Emmanuel Amzallag, Vladislav Krupalnik, Michael Mullokandov, Alon Silberman, Ayelet Erez and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. MTCH2 Suppresses Thermogenesis by Regulating Autophagy in Adipose Tissue.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  12. Review
  13. Article
  14. Article
  15. Molecular mechanisms of mitochondrial dynamics.Nature reviews. Molecular cell biology · 2025
    Review
  16. Review
  17. Review
  18. Regulating Lipid MetabolismRecent patents on anti-cancer drug discovery · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Amir BahatDepartment of Biological Regulation, Weizmann Institute of Science, 7610001, Rehovot, Israel.
Andres GoldmanDepartment of Biological Regulation, Weizmann Institute of Science, 7610001, Rehovot, Israel.
Yehudit ZaltsmanDepartment of Biological Regulation, Weizmann Institute of Science, 7610001, Rehovot, Israel.
Dilshad H KhanPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Coral HalperinDepartment of Biological Regulation, Weizmann Institute of Science, 7610001, Rehovot, Israel.
Emmanuel AmzallagDepartment of Biological Regulation, Weizmann Institute of Science, 7610001, Rehovot, Israel.
Vladislav KrupalnikDepartment of Molecular Genetics, Weizmann Institute of Science, 7610001, Rehovot, Israel.
Michael MullokandovDepartment of Biological Regulation, Weizmann Institute of Science, 7610001, Rehovot, Israel.
Alon SilbermanDepartment of Biological Regulation, Weizmann Institute of Science, 7610001, Rehovot, Israel.
Ayelet ErezDepartment of Biological Regulation, Weizmann Institute of Science, 7610001, Rehovot, Israel.
Aaron D SchimmerPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Jacob H HannaDepartment of Molecular Genetics, Weizmann Institute of Science, 7610001, Rehovot, Israel.ORCID http://orcid.org/0000-0003-2042-9974
Atan GrossDepartment of Biological Regulation, Weizmann Institute of Science, 7610001, Rehovot, Israel. atan.gross@weizmann.ac.il.
Weizmann Institute of Science · ILUniversity Health Network · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of mitochondria dynamics and its molecular regulators remains largely unknown during naïve-to-primed pluripotent cell interconversion. Here we report that mitochondrial MTCH2 is a regulator of mitochondrial fusion, essential for the naïve-to-primed interconversion of murine embryonic stem cells (ESCs). During this interconversion, wild-type ESCs elongate their mitochondria and slightly alter their glutamine utilization. In contrast, MTCH2

Indexed as

AnimalsCells, CulturedDynaminsGene ExpressionGTP PhosphohydrolasesMiceMice, Inbred C57BLMice, KnockoutMicroscopy, ConfocalMitochondriaMitochondrial DynamicsMitochondrial Membrane Transport ProteinsMouse Embryonic Stem CellsNanog Homeobox ProteinPluripotent Stem CellsDnm1l protein, mouseDynaminsGTP PhosphohydrolasesMfn2 protein, mouseMitochondrial Membrane Transport ProteinsMtch2 protein, mouseNanog Homeobox Protein

Identifiers

PMID30510213
PMCPMC6277412
OpenAlexW2902910139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.